Preferred Label : Prasugrel Hydrochloride;
MeSH definition : A piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent
THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL
INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS.;
MeSH synonym : Hydrochloride, Prasugrel; Prasugrel HCl; HCl, Prasugrel;
MeSH Hyperonym : prasugrel;
MeSH hyponym : efient; LY 640315; CS 747; Effient; 747, CS; CS-747; CS747; 640315, LY; LY640315; LY-640315;
MeSH Related Number : 34K66TBT99; 389574-19-0 (prasugrel hydrochloride);
Wikipedia link : https://en.wikipedia.org/wiki/Prasugrel;
Is substance : O;
UNII : G89JQ59I13;
Origin ID : D000068799;
UMLS CUI : C2683417;
ATC code(s)
- Allowable qualifiers
- Automatic exact mappings (from CISMeF team)
- Manual NTBT mappings (CISMeF)
- Pharmacological action(s)
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
A piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent
THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL
INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS.
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64503651
2021
false
false
false
France
French
Prasugrel Hydrochloride
administration, oral
summary of product characteristics
package leaflet
platelet aggregation inhibitors
prasugrel
---
http://sfar.org/wp-content/uploads/2018/03/2_Gestion-des-agents-antiplaquettaires-pour-une-procedure-invasive-programmee.pdf
https://doi.org/10.1016/j.anrea.2018.01.002
2018
false
false
false
France
French
platelet aggregation inhibitors
hemorrhage
postoperative complications
platelet aggregation inhibitors
embolism and thrombosis
aspirin
administration, oral
Prasugrel Hydrochloride
risk management
risk assessment
continuity of patient care
patient safety
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
platelet aggregation inhibitors excl. heparin
surgical procedures, operative
blood loss, surgical
perioperative period
ticlopidine
ticlopidine
adenosine
adenosine
Clopidogrel
Ticagrelor
---
https://www.ema.europa.eu/medicines/human/EPAR/Prasugrel-Mylan
2018
false
United Kingdom
French
English
syndication feed
Prasugrel Hydrochloride
Prasugrel Hydrochloride
drugs, generic
drug therapy, combination
aspirin
acute coronary syndrome
angioplasty, balloon, coronary
platelet aggregation inhibitors
platelet aggregation inhibitors
adult
drug interactions
pregnancy
breast feeding
tablets
administration, oral
membrane proteins
treatment outcome
drug evaluation, preclinical
thrombosis
atherosclerosis
prasugrel
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
summary of product characteristics
drug evaluation
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_2034340/fr/efient
2015
true
France
French
Prasugrel Hydrochloride
Prasugrel Hydrochloride
platelet aggregation inhibitors
administration, oral
drug therapy, combination
insurance, health, reimbursement
aspirin
atherosclerosis
thrombosis
angioplasty, balloon, coronary
acute coronary syndrome
adult
aged
treatment outcome
myocardial infarction
platelet aggregation inhibitors
evaluation of the transparency committee
---
https://minerva-ebp.be/fr/article/1092
2015
false
false
false
false
minerva-ebm.be
Belgium
French
Dutch
critical appraisal or critical reading
platelet aggregation inhibitors
drug therapy, combination
aspirin
administration, oral
risk assessment
cardiovascular diseases
cardiovascular diseases
Long-Term care
treatment outcome
meta-analysis as topic
Prasugrel Hydrochloride
comparative study
Clopidogrel
---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/37611a-fra.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/37615a-fra.php
2014
false
Canada
French
English
prasugrel
angina, unstable
myocardial infarction
hemorrhage
risk
percutaneous coronary intervention
pharmacovigilance note
patient education handout
Prasugrel Hydrochloride
---
http://www.has-sante.fr/portail/jcms/c_1710205/fr/antiagregants-plaquettaires-prise-en-compte-des-risques-thrombotique-et-hemorragique-pour-les-gestes-percutanes-chez-le-coronarien
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-12/recommandations_antiagregants_plaquettaires_-_gestes_percutanes.pdf
http://www.has-sante.fr/portail/jcms/c_1710202/fr/fiche-de-synthese-antiagregants-plaquettaires-gestes-percutanes
2013
true
France
French
CORONARY STENT, OTHER
Prasugrel Hydrochloride
Prasugrel Hydrochloride
platelet aggregation inhibitors
platelet aggregation inhibitors
coronary disease
hemorrhage
risk management
guidelines for drug use
injections, Intra-Articular
bone marrow examination
biopsy
aspirin
aspirin
platelet aggregation inhibitors excl. heparin
thrombosis
punctures
biopsy, needle
cementoplasty
biopsy, Large-Core needle
biopsy, fine-needle
spinal puncture
nephrostomy, percutaneous
drug combinations
dipyridamole
administration, oral
pravastatin
risk assessment
practice guideline
angioplasty
chest tubes
stents
ticlopidine
adenosine
Clopidogrel
Clopidogrel
Ticagrelor
Ticagrelor
---
https://www.ema.europa.eu/medicines/human/EPAR/Efient
2012
false
United Kingdom
French
English
syndication feed
Prasugrel Hydrochloride
Prasugrel Hydrochloride
drug therapy, combination
aspirin
acute coronary syndrome
angioplasty, balloon, coronary
platelet aggregation inhibitors
platelet aggregation inhibitors
adult
drug interactions
pregnancy
breast feeding
tablets
administration, oral
membrane proteins
treatment outcome
drug evaluation, preclinical
thrombosis
atherosclerosis
prasugrel
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
summary of product characteristics
drug evaluation
package leaflet
---
https://www.pharmacoclin.ch/_library/pdf/COMED6.pdf
2011
false
Switzerland
French
journal article
Prasugrel Hydrochloride
Prasugrel Hydrochloride
ticlopidine
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
purinergic P2Y receptor antagonists
Cost-Benefit analysis
platelet aggregation inhibitors
prasugrel
clopidogrel
Clopidogrel
Clopidogrel
---
Summary Basis of Decision (SBD) EFFIENT - Prasugrel hydrochloride
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00047
2010
false
Canada
English
French
Prasugrel Hydrochloride
platelet aggregation inhibitors
drug therapy, combination
aspirin
prasugrel
drug approval
canada
acute coronary syndrome
atherosclerosis
thrombosis
drug evaluation
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-08/efient_-_ct-6544.pdf
http://www.has-sante.fr/portail/jcms/c_875004/efient-10-mg-prasugrel-antiagregant-plaquettaire
2009
false
France
French
Prasugrel Hydrochloride
Prasugrel Hydrochloride
platelet aggregation inhibitors
administration, oral
drug therapy, combination
insurance, health, reimbursement
aspirin
atherosclerosis
thrombosis
angioplasty, balloon, coronary
acute coronary syndrome
adult
aged
treatment outcome
myocardial infarction
platelet aggregation inhibitors
evaluation of the transparency committee
guidelines for drug use
---
https://www.cadth.ca/sites/default/files/pdf/368_No63_prasugrel_edrug_f.pdf
2005
false
Canada
French
Prasugrel Hydrochloride
drugs, investigational
angioplasty, balloon, coronary
angina, unstable
acute coronary syndrome
platelet aggregation inhibitors
canada
prasugrel
purinergic P2Y receptor antagonists
drug evaluation
---
